Fungus labeled ‘urgent threat' by CDC is spreading rapidly, hospital study finds
(NEXSTAR) – New cases of a dangerous, drug-resistant fungus have been identified in at least two states' hospital systems.
Candida auris, also called C. auris, was first identified in the U.S. in 2016. Since then, the number of cases have increased every year, jumping substantially in 2023 (the last year of data available from the Centers for Disease Control and Prevention).
Recently, cases have proliferated in Georgia, the state's health department told local news outlet WJCL. A study published this week, which focused on the Jackson Health System in Miami also found cases of the fungus have 'rapidly increased.'
Allergy sufferers in these US cities face a tough 2025 season, study finds
The CDC has called Candida auris ' an urgent antimicrobial resistance threat ' because it's resistant to anti-fungal drugs, making it hard to treat an infection once it occurs.
'If you get infected with this pathogen that's resistant to any treatment, there's no treatment we can give you to help combat it. You're all on your own,' Melissa Nolan, an assistant professor of epidemiology and biostatistics at the University of South Carolina, told Nexstar.
People with a healthy immune system may be able to fight off infection on their own, but Candida auris mainly spreads in health care settings, where people are sick and vulnerable. People with catheters, breathing tubes, feeding tubes and PICC lines are at the highest risk because the pathogen can enter the body through these types of devices.
When the fungus infects a patient, it can be hard to identify what's going on. Symptoms are like those of any infection, including fever and chills.
Another reason Candida auris is so concerning is because of how well it has adapted to surviving on surfaces, like countertops, bedrails and doorknobs.
'It's really good at just being, generally speaking, in the environment,' Nolan explained. 'So if you have it on a patient's bed for example, on the railing, and you go to wipe everything down, if in whatever way maybe a couple of pathogens didn't get cleared, then they're becoming resistant. And so over time, they can kind of grow and populate in that hospital environment.'
It's not just hospitals in Georgia and Florida that are areas of concern. Candida auris has been found in all but 12 states, with a substantial spike between 2022 and 2023.
Location Clinical cases of C. auris
Alaska 0
Alabama 19
Arkansas 10
Arizona 179
California 1,566
Colorado 3
Connecticut 8
District Of Columbia 97
Delaware 30
Florida 1,485
Georgia 219
Hawaii 1
Iowa 6
Idaho 0
Illinois 1,627
Indiana 304
Kansas 0
Kentucky 48
Louisiana 38
Massachusetts 23
Maryland 203
Maine 0
Michigan 149
Minnesota 8
Missouri 4
Mississippi 41
Montana 0
North Carolina 20
North Dakota 0
Nebraska 2
New Hampshire 0
New Jersey 491
New Mexico 1
Nevada 1,008
New York 1,795
Ohio 274
Oklahoma 10
Oregon 4
Pennsylvania 44
Rhode Island 0
South Carolina 8
South Dakota 0
Tennessee 107
Texas 750
Utah 1
Virginia 151
Vermont 0
Washington 0
Wisconsin 12
West Virginia 4
Wyoming 0
In the past, the CDC estimated that 'based on information from a limited number of patients, 30–60% of people with C. auris infections have died. However, many of these people had other serious illnesses that also increased their risk of death.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
SNHD identifies 4 cases of salmonella in Clark County linked to multi-state outbreak
LAS VEGAS (KLAS) — The Southern Nevada Health District identified several cases of salmonella in Clark County in connection to a multi-state outbreak linked to brown eggs. The SNHD identified four cases of salmonella in Clark County as of Wednesday as the Centers for Disease Control and Prevention (CDC) leads a coordinated investigation into the outbreak linked to brown cage-free and brown-certified organic eggs. As of Wednesday, at least 50 salmonella-related illnesses have been reported nationwide. Salmonella can cause serious illness and symptoms typically begin six hours to six days after exposure. Symptoms include diarrhea, fever and stomach cramps. Salmonella outbreak tied to eggs sickens dozens across 7 states SNHD said most people recover without medical treatment, but some, especially young children, older adults, and people with weakened immune systems are at greater risk of developing severe illnesses or complications that may require hospitalization. The CDC is advised the following: Do not eat any recalled eggs. Throw them away or return them to where you bought them. Wash items and surfaces that may have touched the recalled eggs using hot soapy water or a dishwasher. Call your health care provider if you have any of these severe Salmonella symptoms: Diarrhea or vomiting lasting more than two days A fever higher than 102°F Bloody diarrhea or bloody urine So much vomiting that you cannot keep liquids down Signs of dehydration, such as not peeing much, dry mouth and throat, and feeling dizzy when standing up For more information about the outbreak, including safety tips and product recall details, is available on the CDC's website or on the U.S. Food and Drug Administration website. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
CBS News
an hour ago
- CBS News
CDC purges career officials from oversight of vaccine committee
Career officials at the Centers for Disease Control and Prevention responsible for overseeing the agency's committee of outside vaccine experts have been removed from their role in the process, multiple CDC officials tell CBS News. News of their removal comes the same week Health and Human Services Secretary Robert F. Kennedy Jr. fired all the members of the CDC's Advisory Committee on Immunization Practices, known as ACIP, and replaced them with eight new picks that include close allies and COVID vaccine critics. The next meeting of the committee is coming up at the end of June. The vaccine recommendations from the committee are closely watched by state and local authorities, health care providers and others because they are tied to several federal policies that enable access to the shots, including requirements for insurance coverage and programs for uninsured children. Multiple federal health officials said the staffers removed from overseeing the panel included Dr. Melinda Wharton, the associate director for vaccine policy, and her team at the agency's National Center for Immunization and Respiratory Diseases. A CDC spokesperson did not immediately respond to a request for comment. Wharton had served as the committee's executive secretary before she was pulled from her role. Among other things, she and her team had been responsible for vetting nominees for ACIP membership, which would usually include extensive screening for potential conflicts of interest before someone would be named to the committee. Multiple CDC officials said that Kennedy circumvented the CDC's process to pick his new members of the committee. HHS said in an "ACIP FAQ" document shared with members of Congress and stakeholders that Kennedy's new picks for the committee were being selected "through a rigorous examination of their scientific credentials and a comprehensive ethics review for potential conflicts of interest." Wharton and her team had also overseen the panel's operations, including prioritizing its agenda and planning meetings for work groups that huddle to discuss technical details between the committee's public discussions and votes. ACIP work group planning meetings have since been postponed due to the lack of voting committee members to attend them, multiple people familiar with the matter told CBS News. Those people said the CDC's chief of staff, Matt Buzzelli, an appointee of the Trump administration, was now effectively in charge of the committee's planning. Buzzelli is seen by many within the agency as the CDC's de facto head, in the absence of a Senate confirmed director or acting director appointed by Kennedy. One former CDC official said the move amounted to "putting RFK like-minded people and removing all potential internal CDC opposition" in the committee, calling it far from normal. Dr. Lakshmi Panagiotakopoulos, one of the CDC officials overseeing the work group on COVID-19 vaccines, resigned last week after Kennedy ordered edits to the CDC's recommendations to exclude children and pregnant women. Several medical groups criticized Kennedy's move at the time to bypass the committee and its COVID-19 vaccines work group. The American Pharmacists Association is among those now withholding endorsement of the CDC's new adult immunization schedule.
Yahoo
2 hours ago
- Yahoo
Kennedy names new members of CDC vaccine advisory panel days after removing previous advisers
Just two days after retiring the entirety of the US Centers for Disease Control and Prevention's vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government's Covid-19 response to that committee. He announced eight new members of the CDC's Advisory Committee on Immunization Practices, or ACIP, on Wednesday. Kennedy had said Monday that the previous 17-member panel that makes recommendations on who should get vaccines and when was rife with conflicts of interest and that he would appoint new 'highly credentialed' experts in time for the panel's June 25 meeting, at which the members are expected to discuss guidance for Covid-19 and HPV shots, among others. In a statement Wednesday, Kennedy said the reassembled panel will demand 'definitive safety and efficacy data before making any new vaccine recommendations, but will also review data for the current vaccine schedule as well.' The eight new ACIP members include Dr. Robert Malone, a biochemist who made early innovations in the field of messenger RNA but in more recent years has been a vocal critic of mRNA technology in Covid-19 vaccines. The CDC recently narrowed its recommendations for mRNA Covid-19 shots, but some advocates in the Make America Healthy Again space have pressed Kennedy to go further and bar the vaccines entirely. Another new member is Dr. Martin Kulldorff, a biostatistician and epidemiologist who co-authored an October 2020 strategy on herd immunity known as the Great Barrington Declaration with Dr. Jay Bhattacharya, now director of the US National Institutes of Health. Both Malone's and Kulldorff's names were circulated early in the second Trump administration as potential advisers on ACIP or other panels, according to a person familiar with the process who requested anonymity because they weren't authorized to speak with CNN. Kennedy also chose Dr. James Pagano, an emergency medicine physician he described as a 'strong advocate for evidence-based medicine' who has served on hospital committees and medical executive boards. Dr. Retsef Levi, an MIT professor who has published studies on mRNA vaccines and cardiovascular events, is also joining the panel. Levi is a professor of operations management. Several of the new members have served in federal health agencies previously, including Dr. Joseph Hibbeln, a former acting chief of the NIH's section on nutritional neurosciences. Dr. Cody Meissner, a Dartmouth professor of pediatrics who also signed the Great Barrington Declaration, has previously served on ACIP and on the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee. Dr. Vicky Pebsworth, the Pacific region director of the National Association of Catholic Nurses, also served on the FDA committee and on a national panel reviewing the 2009 H1N1 swine flu vaccine. Dr. Michael Ross, a professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University, has previously served on the CDC's Advisory Committee for the Prevention of Breast and Cervical Cancer. Kennedy also nodded in his statement to Ross' 'continued service on biotech and healthcare boards.' The private equity company Havencrest, in which Ross is an operating partner, describes him on its site as a 'serial CEO' who has served on the boards of several biotechnology companies.
